SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001659617-20-000106
Filing Date
2020-04-17
Accepted
2020-04-17 16:04:11
Documents
19
Period of Report
2020-04-16
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-kq22020investorwebin.htm 8-K 21790
2 EXHIBIT 99.1 mbrxconferencecallslides.htm EX-99.1 23168
3 mbrxconferencecallslides001.jpg GRAPHIC 91638
4 mbrxconferencecallslides002.jpg GRAPHIC 164913
5 mbrxconferencecallslides003.jpg GRAPHIC 105643
6 mbrxconferencecallslides004.jpg GRAPHIC 98824
7 mbrxconferencecallslides005.jpg GRAPHIC 149055
8 mbrxconferencecallslides006.jpg GRAPHIC 88874
9 mbrxconferencecallslides007.jpg GRAPHIC 79300
10 mbrxconferencecallslides008.jpg GRAPHIC 94776
11 mbrxconferencecallslides009.jpg GRAPHIC 143892
12 mbrxconferencecallslides010.jpg GRAPHIC 106907
13 mbrxconferencecallslides011.jpg GRAPHIC 143537
14 mbrxconferencecallslides012.jpg GRAPHIC 91069
15 mbrxconferencecallslides013.jpg GRAPHIC 80068
16 mbrxconferencecallslides014.jpg GRAPHIC 84231
17 mbrxconferencecallslides015.jpg GRAPHIC 97909
18 mbrxconferencecallslides016.jpg GRAPHIC 91974
19 moleculin-logo_horiza33.jpg GRAPHIC 132868
  Complete submission text file 0001659617-20-000106.txt   2579341
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 20799700
SIC: 2834 Pharmaceutical Preparations